A multinational team led by Weill Cornell Medicine investigators developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa—a vital tool in the search ...
Jul 2, 2024
0
55
A study published in the Aug. 22, 2022, issue of Nature Medicine identifies a new biomarker that appears effective as a surrogate endpoint to reliably predict the ability of broadly neutralizing monoclonal antibodies to prevent ...
Aug 22, 2022
0
37
Carefully designed cocktails of broadly neutralizing antibodies (bNAbs) could help treat HIV while minimizing the risk of the virus escaping treatment, suggests a study published today in eLife.
Jul 19, 2022
0
33
The proof-of-concept AMP studies demonstrated that a broadly neutralizing antibody (bnAb) called VRC01 was effective at preventing the acquisition of HIV strains to the 30% of strains that were sensitive to the bnAb. This ...
Mar 17, 2021
0
25
The discovery of a rare new strain of HIV for the first time in nearly 20 years recently made headlines around the world.
Feb 6, 2020
0
5
Scientist Mary Rodgers spends her days tracking killers—elusive, constantly mutating viruses that travel the globe and are responsible for illness or death in millions of people. Wednesday, in an article published in the ...
Nov 7, 2019
0
52
Antiretroviral therapy (ART) can suppress HIV to the point where the virus is nearly undetectable, and people on medication can live many years. But therapy cannot completely eradicate the virus; it persists in reservoirs ...
Oct 9, 2019
0
266
Antiretroviral therapy (ART) is usually very effective at suppressing HIV in the body, allowing a person's immune system to recover by preventing the virus from destroying CD4+ T cells. Scientists have now identified a rare, ...
Apr 18, 2019
0
0
A study from a Massachusetts General Hospital (MGH) research team has identified the specific function of a protein found in HIV and related viruses that appears to slow down viral spread in the earliest stages of infection. ...
Jan 10, 2019
0
72
Distinct HIV-1 strains may differ in the nature of the CCR5 molecules to which they bind, affecting which cells they can infect and their ability to enter cells, according to a study published December 6 in the open-access ...
Dec 6, 2018
0
24
